Compare MRNA & BJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | BJ |
|---|---|---|
| Founded | 2010 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 12.9B |
| IPO Year | 2018 | 2018 |
| Metric | MRNA | BJ |
|---|---|---|
| Price | $55.54 | $95.82 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 16 |
| Target Price | $33.00 | ★ $108.80 |
| AVG Volume (30 Days) | ★ 9.6M | 1.7M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.77 | 3.09 |
| EPS | N/A | ★ 3.42 |
| Revenue | $19,263,000,000.00 | ★ $20,501,804,000.00 |
| Revenue This Year | $8.28 | $9.10 |
| Revenue Next Year | $16.53 | $6.71 |
| P/E Ratio | ★ N/A | $28.27 |
| Revenue Growth | ★ 4.29 | 2.67 |
| 52 Week Low | $22.28 | $86.68 |
| 52 Week High | $59.55 | $121.10 |
| Indicator | MRNA | BJ |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 44.66 |
| Support Level | $23.74 | $95.12 |
| Resistance Level | N/A | $99.52 |
| Average True Range (ATR) | 3.84 | 3.09 |
| MACD | 0.26 | -0.48 |
| Stochastic Oscillator | 69.97 | 40.20 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
BJ's Wholesale Club, founded in 1984, operates a membership-based warehouse club model primarily along the US East Coast, with roughly 250 clubs and a growing domestic presence across 21 states. In fiscal 2024, the company generated over $20 billion in revenue. BJ's offers a value-oriented assortment skewed toward grocery, perishables, and consumables (71% of sales), general merchandise (11%), and gasoline (18%). Its business model is supported by recurring membership fee income and private-label brands such as Wellsley Farms and Berkley Jensen.